前往化源商城

4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐

更新时间:2025-08-25 21:29:49

4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐结构式
4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐结构式
品牌特惠专场
常用名 4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐 英文名 cis-N-Methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride
CAS号 79617-89-3 分子量 342.690
密度 N/A 沸点 443.8ºC at 760 mmHg
分子式 C17H18Cl3N 熔点 275-277ºC
MSDS N/A 闪点 222.2ºC
符号 GHS07
GHS07
信号词 Warning

 用途


舍曲林中间体

 名称

中文名 舍曲林碱
英文名 cis-N-Methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride
中文别名 4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐
英文别名 更多

 物理化学性质

沸点 443.8ºC at 760 mmHg
熔点 275-277ºC
分子式 C17H18Cl3N
分子量 342.690
闪点 222.2ºC
精确质量 341.050476
PSA 12.03000
LogP 6.37250
InChIKey BLFQGGGGFNSJKA-UHFFFAOYSA-N
SMILES CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl

 安全信息

符号 GHS07
GHS07
信号词 Warning
危害声明 H302-H412
警示性声明 P273
危险品运输编码 NONH for all modes of transport

 合成线路

~78%

4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐结构式

4-(3,4-二氯苯基)-1,...

79617-89-3

文献:UNICHEM LABORATORIES LIMITED Patent: WO2007/119247 A2, 2007 ; Location in patent: Page/Page column 23 ;

~%

4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐结构式

4-(3,4-二氯苯基)-1,...

79617-89-3

文献:WO2007/124920 A1, ; Page/Page column 14-15 ;

~%

4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐结构式

4-(3,4-二氯苯基)-1,...

79617-89-3

文献:US2006/14838 A1, ; Page/Page column 2-3 ;

 文献3

更多文献
Development and validation of LC-MSMS assay for the determination of the prodrug dabigatran etexilate and its active metabolites in human plasma.

J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 989 , 37-45, (2015)

Dabigatran etexilate (DABE) is a low-molecular-weight prodrug that is converted after oral administration to dabigatran (DAB)-a directly acting oral anticoagulant. In this study, an LC-MSMS assay was ...

Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.

J. Ethnopharmacol. 155(3) , 1473-82, (2014)

Schisandra chinensis (SC), officially listed as a sedative and tonic in the Chinese Pharmacopoeia, has been used as a common component in various prescriptions in Traditional Chinese Medicine (TCM) an...

Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing.

Neuropsychopharmacology 39(12) , 2709-22, (2014)

Posttraumatic stress disorder (PTSD) can develop following exposure to a traumatic event. Hence, what we do in the first few hours after trauma exposure may alter the trajectory of PTSD. We examined w...

 英文别名

cis-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride
[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]methylamine hydrochloride
4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride (1:1)
cis-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthaleneamine hydrochloride
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride (1:1)
4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride
cis(1S,1R)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-terahydro-1-(2H)-napthalenamine hydrochloride
(+/-)-sertraline hydrochloride
4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride (1:1)
4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPHTHALENAMINEHYDROCHLORIDE
Sertraline Hydrochloride Racemic Mixture (25 mg) (1:1 mixture of (1S,4S) and (1R,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride)
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
相关化合物: 更多...
4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐
79617-99-5
(1S-顺式)-4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐
79559-97-0
(1r,4r)-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺盐酸盐
675126-09-7
(1S,4S)-N-去甲基舍曲林盐酸盐
675126-10-0
舍曲林
79617-96-2
顺式-4-(4-氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐
79559-98-1
顺式4-(3,4-二氯苯基)-1,2,3,4-四氢-N-boc-1-萘胺
267884-84-4
4-(3,4-二氯苯)-1,2,3,4-四氢-N-甲基-1-萘胺
140631-53-4
4-(3,4-二氟苯基)-1,2,3,4-四氢-6-甲基-2-氧代-5-嘧啶羧酸
356566-58-0
(2Z)-6-chloro-2-[(3-chloro-4-methylphenyl)imino]-N-[(oxolan-2-yl)methyl]-2H-chromene-3-carboxamide
1327170-11-5
(2Z)-6-chloro-2-[(3-chloro-4-methoxyphenyl)imino]-N-[(oxolan-2-yl)methyl]-2H-chromene-3-carboxamide
1327170-14-8
(2Z)-6-chloro-2-[(5-chloro-2-methoxyphenyl)imino]-N-(tetrahydrofuran-2-ylmethyl)-2H-chromene-3-carboxamide
1327179-31-6
(2Z)-6-chloro-2-{[4-(methylsulfanyl)phenyl]imino}-N-(tetrahydrofuran-2-ylmethyl)-2H-chromene-3-carboxamide
1327172-09-7
(2Z)-6-chloro-2-[(2-fluoro-5-methylphenyl)imino]-N-[(oxolan-2-yl)methyl]-2H-chromene-3-carboxamide
1327175-49-4
(2Z)-6-chloro-2-[(4-chloro-3-methylphenyl)imino]-N-(tetrahydrofuran-2-ylmethyl)-2H-chromene-3-carboxamide
1327172-72-4
(2Z)-6-chloro-2-[(3-fluoro-4-methoxyphenyl)imino]-N-(tetrahydrofuran-2-ylmethyl)-2H-chromene-3-carboxamide
1327195-34-5
(2Z)-6-chloro-2-[(5-chloro-2-fluorophenyl)imino]-N-(tetrahydrofuran-2-ylmethyl)-2H-chromene-3-carboxamide
1327196-06-4
(2Z)-6-chloro-2-[(3-fluoro-2-methylphenyl)imino]-N-(tetrahydrofuran-2-ylmethyl)-2H-chromene-3-carboxamide
1327181-29-2
(2Z)-2-[(2,4-difluorophenyl)imino]-8-methoxy-N-(pyridin-2-yl)-2H-chromene-3-carboxamide
1327172-79-1